Assessment of Vedolizumab Disease‐Drug‐Drug Interaction Potential in Patients With Inflammatory Bowel Diseases

Disease‐drug‐drug interactions (DDDIs) have been identified in some inflammatory diseases in which elevated proinflammatory cytokines can downregulate the expression of cytochrome P450 (CYP) enzymes, potentially increasing systemic exposure to drugs metabolized by CYPs. Following anti‐inflammatory t...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wan, Lirio, Richard A., Schneider, Jennifer, Aubrecht, Jiri, Kadali, Harisha, Baratta, Mike, Gulati, Parul, Suri, Ajit, Lin, Tiffany, Vasudevan, Raghavan, Rosario, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359401/
https://www.ncbi.nlm.nih.gov/pubmed/33331142
http://dx.doi.org/10.1002/cpdd.891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359401/
https://www.ncbi.nlm.nih.gov/pubmed/33331142
http://dx.doi.org/10.1002/cpdd.891

Ejemplares similares